New ad urges Congress to take action on drug prices
The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, yesterday released a new ad urging Congress to keep its commitment to lower drug prices. Seventeen organizations, including the AHA, this month urged Congress to resist any attempts from the pharmaceutical industry to undo during the lame duck session provisions included in the Bipartisan Budget Act to make prescription drugs more affordable for seniors. The legislation closes the Medicare Part D coverage gap or “doughnut hole” one year earlier and requires higher drug manufacturer discounts on brand name prescription drugs while enrollees are in the coverage gap.
Related News Articles
Headline
The Department of Health and Human Services Office of Inspector General yesterday released a bulletin addressing how direct-to-consumer drug programs can sell…
Headline
The Centers for Medicare & Medicaid Services yesterday announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations.…
Headline
A KFF analysis released today found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…
Headline
The Centers for Medicare & Medicaid Services Jan. 26 released proposed changes to Medicare Advantage plan capitation rates and Part D payment policies for…
Headline
The AHA Jan. 26 expressed support and provided its perspective on certain provisions within the Centers for Medicare & Medicaid Services’ proposed…
Headline
The AHA Jan. 20 made recommendations to Congress on modernizing the Medicare Access and CHIP Reauthorization Act. Among the proposals, the AHA recommended…